Detalhe da pesquisa
1.
Exploring the potential of neem and tamarind gum as release retardants: Design and statistical optimisation of vildagliptin extended release matrix systems using D-optimal quadratic mixture design.
Int J Biol Macromol
; 259(Pt 1): 129136, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181924
2.
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants.
NPJ Vaccines
; 9(1): 41, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383584
3.
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.
Lancet Reg Health Southeast Asia
; 19: 100256, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076719
4.
Ethyl 4-(2-fur-yl)-2-oxochroman-3-carboxyl-ate.
Acta Crystallogr Sect E Struct Rep Online
; 66(Pt 6): o1310, 2010 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21579405
5.
Temporomandibular pain.
J Oral Maxillofac Pathol
; 20(2): 272-5, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601822
6.
Influence of colon degradation of polysaccharide on the oral bioavailability of theophylline from controlled release hydrophilic matrices.
Boll Chim Farm
; 142(10): 454-60, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14971315
7.
Nimesulide-modified gum karaya solid mixtures: preparation, characterization, and formulation development.
Drug Dev Ind Pharm
; 29(8): 855-64, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-14570306